The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin

Abstract

In haemodialysis patients on maintenance erythropoietin, Hypo >6% is the best currently available marker to identify those who will improve their response after intravenous iron. Cost-effectiveness suggests that this parameter should be a first-line tool to monitor iron requirements in clinical practice.